Edison Alberto

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials

Zulfiqar A Bhutta, María Rosario Capeding, Ashish Bavdekar et al. · The Lancet Infectious Diseases · 2013 · 132 citations

Vaccinology, Vaccine Safety, Vaccination +11

Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial

Steve Cunningham, Pedro A. Piedra, Federico Martinón‐Torres et al. · The Lancet Respiratory Medicine · 2020 · 123 citations · Full text

Respiratory Syncytial Virus, Respiratory Diseases, Hospitalised Children +8

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

Lulu Bravo, Igor Smolenov, Htay Htay Han et al. · The Lancet · 2022 · 112 citations · Full text

Vaccinology, Vaccine Safety, Vaccination +9

The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity

Nancy Bermal, Leszek Szenborn, Andrzej Chrobot et al. · The Pediatric Infectious Disease Journal · 2009 · 93 citations

SAFETY AND IMMUNOGENICITY OF A BOOSTER DOSE OF THE 10-VALENT PNEUMOCOCCAL NONTYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D CONJUGATE VACCINE COADMINISTERED WITH DTPW-HBV/HIB AND POLIOVIRUS VACCINES

Nancy Bermal, Leszek Szenborn, Edison Alberto et al. · The Pediatric Infectious Disease Journal · 2010 · 31 citations

Vaccination, Vaccine Safety, Effective Priming +12